Ireland vs New Zealand: Prevalence rate of hypertension in women aged 30-79
Ireland
26.6
in 2019
New Zealand
27.6
in 2019
Ireland rank
167th
New Zealand rank
164th
Prevalence rate of hypertension in women aged 30-79 over time
- Ireland
- New Zealand
How they compare
New Zealand currently reports 27.6 against 26.6 in Ireland, a difference of 1.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Ireland ahead.
Ireland ranks 167th and New Zealand ranks 164th of 195 countries.
Across the 3 decades both report, Ireland averaged higher in 1 and New Zealand in 2.
Head to head by decade
| Decade | Ireland | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 32.15 | 31.27 | 0.88 | Ireland |
| 2000s | 30 | 30.15 | 0.15 | New Zealand |
| 2010s | 27.72 | 28.63 | 0.91 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Ireland or New Zealand?
- New Zealand, at 27.6 against 26.6 in Ireland as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Ireland and New Zealand?
- 1, with New Zealand ahead.
- How many years of comparable data are there for Ireland and New Zealand?
- 30 years are reported by both, from 1990 to 2019.
- How do Ireland and New Zealand rank globally for prevalence rate of hypertension in women aged 30-79?
- Ireland ranks 167th and New Zealand ranks 164th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.